Mortality and Pre‐Hospitalization Use of Renin‐Angiotensin System Inhibitors in Patients with Hypertension and Coronavirus Disease 2019 (COVID‐19)

Mortality and Pre‐Hospitalization Use of Renin‐Angiotensin System Inhibitors in Patients with Hypertension and Coronavirus Disease 2019 (COVID‐19)

Background There has been significant controversy about the effects of pre‐hospitalization use of renin‐angiotensin system (RAS) inhibitors on the prognosis of patients with hypertension and coronavirus disease 2019. Methods and Results We retrospectively assessed 2297 hospitalized patients with cor...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Chen Chen, Feng Wang, Peng Chen, Jiangang Jiang, Guanglin Cui, Ning Zhou, Francesco Moroni, Javid J. Moslehi, Enrico Ammirati, Dao Wen Wang
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Wiley 2020-11-01
Seri Bilgileri:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Konular:
angiotensin‐converting enzyme inhibitors
angiotensin‐converting enzyme‐2
angiotensin receptor blockers
COVID‐19
severe acute respiratory syndrome coronavirus‐2
Online Erişim:https://www.ahajournals.org/doi/10.1161/JAHA.120.017736

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.017736

Benzer Materyaller